• March 19, 2015
    LONDON, UK - March 19, 2015 - Leading animal health company Zoetis Inc. unveiled its Centre for Digital Innovation (CDI) at the House of Lords today. Opened in the heart of London’s Tech City, the new Centre will create sophisticated digital products that enable data-driven decision-making to enhance precision farming and improve animal wellbeing for livestock and pets.Hosted by Lord Trees, the event was introduced by Lord de Mauley and attended by industry representatives including themore...
  • January 12, 2015
    NOTTINGHAM, UK - Jan. 12, 2015 -The University of Nottingham has secured funding from Biotechnology and Biological Sciences Research Council (BBSRC) to undertake a four-year project with Zoetis, the leading global animal health company, with the aim of improving feed efficiency in pig farming.This new project builds on an ongoing partnership between The University of Nottingham and Zoetis and will focus on studies to help maximize muscle growth and improve the health of pig herds on farms.more...
  • January 7, 2015
    FLORHAM PARK, N.J., Jan. 7, 2015 — Fostera® PRRS, from Zoetis, is now licensed for whole herd protection against both the respiratory and reproductive forms of disease caused by porcine reproductive and respiratory syndrome (PRRS) virus.The new reproductive claim, recently granted by the U.S. Department of Agriculture (USDA), allows for vaccination of sows and gilts prebreeding to help provide protection against the reproductive form of the disease. The new respiratory claim allows formore...
  • November 24, 2014
    DURHAM, N.C. - November 24, 2014 – Zoetis Inc. today announced the reintroduction of Zoamix® (zoalene), a versatile synthetic anticoccidial for the prevention and control of coccidiosis in broilers and turkeys.“The U.S. poultry industry loses an estimated $600 million a year to coccidiosis[i], so the return of Zoamix could not be coming at a better time,” said Don Waldrip, DVM, DACPV, a senior technical services veterinarian with Zoetis.He noted that U.S. poultry producers have not seen a newmore...
  • September 3, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that the U.S. Department of Agriculture (USDA) has granted a conditional license for a vaccine to help fight porcine epidemic diarrhea virus (PEDv) in pigs. The two-dose inactivated vaccine, licensed for use in healthy pregnant female pigs (sows and gilts), is designed to help them develop antibodies which can be transmitted to their newborn piglets. Zoetis anticipates the vaccine will be available tomore...
  • August 27, 2014
    DURHAM, N.C., August 27, 2014 – Zoetis Inc. has obtained a full license from the U.S. Department of Agriculture (USDA) to sell Poulvac® Bron GA 08, the first commercially available vaccine to reduce disease caused by Georgia 2008 (GA 08) Type infectious bronchitis virus (IBV) in poultry.Poulvac® Bron GA 08, a live vaccine, is licensed for vaccination of healthy chickens at one day of age or older as an aid in the reduction of disease caused by GA 08. The vaccine was licensed based on clinicalmore...
  • August 20, 2014
    FLORHAM PARK, N.J., Aug. 20, 2014 — Fostera™ PCV MH — the porcine circovirus (PCV) and Mycoplasma hyopneumoniae (M. hyo) combination vaccine that was built from the ground up by Zoetis — now has the longest demonstrated duration of immunity (DOI) to help protect pigs from porcine circovirus-associated disease (PCVAD) caused by PCV Type 2 (PCV2). The U.S. Department of Agriculture has granted the combination vaccine the extended label claim of at least 23 weeks of protection against PCV2, whichmore...
  • February 10, 2014
    FLORHAM PARK, N.J., Feb. 10, 2014 — Zoetis Inc. today announced a research partnership with Iowa State University (ISU) to identify and test a vaccine candidate to help control porcine epidemic diarrhea virus (PEDv) in the United States.  “Establishing this partnership further affirms our commitment to fighting this devastating virus,” said Gloria Basse, vice president, U.S. Pork Business Unit, Zoetis. “We look forward to working with the top researchers at Iowa State University to sharemore...
  • February 7, 2014
    DURHAM, N.C. - February 7, 2014 – Zoetis Inc. has obtained a conditional license from the U.S. Department of Agriculture (USDA) to market  the first commercially available vaccine for helping reduce disease caused by the Georgia 08 variant of infectious bronchitis virus (IBV) in poultry*. The vaccine is now available in Alabama, Florida, Georgia, Kentucky and Tennessee. The USDA agreed to issue a conditional license because the modified-live vaccine fills a special need, has beenmore...
  • December 17, 2013
    Zoetis is part of a consortium of 22 academic, industry and private enterprise organizations from 11 countries who are exploring new ways to ensure the sustainability of modern animal production. The consortium was recently awarded the largest animal health grant in EU history. Read the full press release here.more...